Top Markets
#1 Official Trump Official Trump +32.45%
#2 EXOD EXOD +22.08%
#3 Movement Movement +21.25%
#4 Mubarak Mubarak +19.14%
#5 POL (ex-MATIC) POL (ex-MATIC) +18.85%
#6 Wrapped POL Wrapped POL +18.83%
#7 Pearl Pearl +17.90%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +17.22%
#9 Melania Meme Melania Meme +16.21%
#10 Glidr Glidr +11.25%
Coin of the day
Official Trump Official Trump
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
MaaT Pharma S.A. MaaT Pharma S.A.

MaaT Pharma S.A.

MAAT
Clasificación en acciones #23616
MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on... MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on the discovery and advancement of microbiome-based biotherapies, primarily for the treatment of solid cancer tumors. Its development pipeline features MaaT013, which has successfully completed Phase 2 clinical trials for acute graft-versus-host disease (aGVHD) and is also undergoing preclinical evaluation for melanoma. Another therapeutic candidate, MaaT033, is currently in Phase 1b clinical trials, aiming to improve survival outcomes for patients with acute myeloid leukemia (AML) or other liquid malignancies following allogeneic hematopoietic stem cell transplantation. Furthermore, MaaT03X is being developed specifically for solid tumor applications. The company was founded in 2014 and maintains its headquarters in Lyon, France.
Precio por acción
$3.78
Última sincronización: 2026-08-21
Capitalización bursátil
$71.20M
Cambio (1 día)
2.24%
Cambio (1 año)
-43.37%
País
FR
Comercio MaaT Pharma S.A. (MAAT)

Categoría

Healthcare
Ratio P/S de MaaT Pharma S.A. (MAAT)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de MaaT Pharma S.A., el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de MaaT Pharma S.A. desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH